Online Database of Chemicals from Around the World

5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine
[CAS# 219715-62-5]

List of Suppliers
Capot Chemical Co., Ltd. China Inquire  
+86 (571) 8558-6718
+86 13336195806
capotchem@gmail.com
sales@capotchem.com
QQ chat
Chemical manufacturer
chemBlink standard supplier since 2006
Alfa Chemistry USA Inquire  
+1 (201) 478-8534
inquiry@alfa-chemistry.com
Chemical distributor since 2012
chemBlink standard supplier since 2012
Zaozhuang Benefit Chemical Co., Ltd. China Inquire  
+86 (632) 440-3508
sales@benefit-chem.com
Benefit-Chem@hotmail.com
Chemical manufacturer
chemBlink standard supplier since 2012
Shandong Huimeng Biotech Co., Ltd. China Inquire  
+86 (530) 884-2888
+86 18523002917
cindy@szgoldenunion.com
Chemical manufacturer since 2013
chemBlink standard supplier since 2016
Complete supplier list of 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine
Identification
Classification Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyrimidine compound
Name 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine
Synonyms 2-Amino-5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidine
Molecular Structure CAS # 219715-62-5, 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine, 2-Amino-5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidine
Molecular Formula C7H9N5O2
Molecular Weight 195.18
CAS Registry Number 219715-62-5
EC Number 875-177-8
SMILES COC1=CN=C(N2C1=NC(=N2)N)OC
Properties
Density 1.61
Melting point 201-203 ºC
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302-H315-H319-H332-H335    Details
Precautionary Statements P261-P280-P305+P351+P338    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Specific target organ toxicity - single exposureSTOT SE3H335
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2AH319
Acute toxicityAcute Tox.4H302
SDS Available
up Discovory and Applicatios
5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine is a heterocyclic compound known for its unique structural and pharmacological properties. This substance, often abbreviated for convenience, has attracted much attention for its potential applications in medicinal chemistry, particularly in the development of therapeutic agents.

The discovery of 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine stemmed from a broader exploration of triazolopyrimidines, a class of compounds that combine structural features of triazole and pyrimidine. These hybrid structures have received a great deal of attention from chemists for their potential biological activities. The synthesis of 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine involves the reaction of appropriate precursors under specific conditions to form this uniquely substituted triazolopyrimidine.

One of the most promising applications of this compound lies in its potential as a therapeutic agent. Preliminary studies have shown that 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine exhibits significant pharmacological activity, including anti-inflammatory, antimicrobial, and anticancer properties. Its anti-inflammatory potential is particularly noteworthy, as inflammation is a common underlying factor in many chronic diseases. By inhibiting key enzymes and pathways involved in inflammatory responses, this compound could help manage diseases such as arthritis, asthma, and inflammatory bowel disease.

In the field of antimicrobial therapy, 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine has shown efficacy against a variety of bacterial and fungal strains. This is critical in the context of rising antibiotic resistance, as new antimicrobial agents are urgently needed to combat resistant pathogens. The compound's ability to interfere with microbial growth and replication makes it a potential candidate for further development into a new antibiotic or antifungal agent.

The anticancer potential of 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine is another area of ​​active research. Early studies have shown that the compound can induce apoptosis (programmed cell death) in cancer cells, a desirable effect for cancer treatment. By targeting a specific molecular pathway that is often dysregulated in cancer, this compound could offer a new approach to treating various types of cancer, including those that are resistant to traditional therapies.

In addition to direct therapeutic applications, 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine is also of great value in the field of medicinal chemistry as a scaffold for drug development. Its unique structure provides a versatile framework that can be modified to enhance desired pharmacological properties or reduce potential side effects. This makes it an attractive starting point for the synthesis of novel compounds with improved efficacy and safety.

In addition to medical applications, 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine has applications in agrochemistry. Given its antimicrobial properties, it could be developed into new agrochemicals for protecting crops from bacterial and fungal diseases. This will help achieve more sustainable agricultural practices by reducing reliance on traditional chemical pesticides, which often have adverse effects on the environment.
Market Analysis Reports
List of Reports Available for 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine
Related Products
2,4-Dimethoxythiophenol  2,5-Dimethoxythiophenol  3,4-Dimethoxythiophenol  3,4-Dimethoxytoluene  3,5-Dimethoxytoluene  2,6-Dimethoxytoluene  2,5-Dimethoxytoluene  4,6-Dimethoxy-1,3,5-triazin-2-amine  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-morpholinium tetrafluoroborate  1-[[2,4-Dimethoxy-3-(tributylstannyl)benzoyl]oxy]-2,5-pyrrolidinedione  11,13-Dimethoxytricyclo[8.2.2.2(4,7)]hexadeca-4(16),6,10,12,13-pentaene-5,15-dione stereoisomer  6,7-Dimethoxy-1(S)-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydroisoquinoline  (3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid methyl ester mixt. with 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide 1(2H)-phthalazinone hydrazone and potassium chloride  3-(6,7-Dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide  4-(6,7-Dimethoxy-4-quinazolinyl)-1-piperazinecarboxylic acid 2-hydroxy-2-methylpropyl ester  6,7-Dimethoxyquinolin-4-amine  6,7-Dimethoxy-1H-quinolin-4-one  4-[(6,7-Dimethoxy-4-quinolinyl)amino]phenol  4-[(6,7-Dimethoxyquinolin-4-yl)oxy]aniline